M Moll, EK Silverman - Annual Review of Medicine, 2024 - annualreviews.org
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. COPD heterogeneity has hampered progress in developing pharmacotherapies …
KA Serban, KA Pratte, C Strange, RA Sandhaus… - …, 2022 - thelancet.com
Summary Background Alpha-1 Antitrypsin (AAT) deficiency (AATD), the most common genetic cause of emphysema presents with unexplained phenotypic heterogeneity in …
SUMMARY OF KEY POINTS International respiratory organizations now recommend using lower limit of normal and standardized residuals to diagnose airflow obstruction and COPD …
The onset of chronic obstructive pulmonary disease (COPD) is heterogeneous, and current approaches to define distinct disease phenotypes are lacking. In addition to clinical …
OF McElvaney, DD Fraughen… - Expert Review of …, 2023 - Taylor & Francis
Introduction Alpha1 antitrypsin deficiency (AATD), a common hereditary disorder affecting mainly lungs, liver and skin has been the focus of some of the most exciting therapeutic …
Background: Bronchoscopic lung volume reduction using one-way endobronchial valves (EBVs) is a valid therapy for severe emphysema patients. However, alpha-1 antitrypsin …
AR Sonawane, E Aikawa, M Aikawa - Frontiers in Cardiovascular …, 2022 - frontiersin.org
Cardiovascular diseases (CVD) are diverse disorders affecting the heart and vasculature in millions of people worldwide. Like other fields, CVD research has benefitted from the deluge …
Abstract Purpose A 1 Antitrypsin deficiency (AATD) pathogenic mutations are expanding beyond the PI* Z and PI* S to a multitude of rare variants. Aim to investigate genotype and …
Background Alpha-1 antitrypsin deficiency is an under-recognized genetic cause of chronic lung and liver disease; it remains unclear what the testing frequency and disparities are for …